175 related articles for article (PubMed ID: 16565906)
21. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.
Kramer HH; Sommer M; Rammos S; Krogmann O
Eur J Pediatr; 1995 Sep; 154(9):700-7. PubMed ID: 8582419
[TBL] [Abstract][Full Text] [Related]
22. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
23. Use of prostaglandins in duct-dependent congenital heart conditions.
Singh Y; Mikrou P
Arch Dis Child Educ Pract Ed; 2018 Jun; 103(3):137-140. PubMed ID: 29162633
[TBL] [Abstract][Full Text] [Related]
24. Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.
Takeda N; Hiraishi S; Misawa H; Agata Y; Horiguchi Y; Fujino N; Hirota H; Kawamura S; Ogawa N
Pediatr Int; 2000 Apr; 42(2):134-8. PubMed ID: 10804727
[TBL] [Abstract][Full Text] [Related]
25. Compliance, alveolar-arterial oxygen difference, and oxygenation index changes in patients managed with extracorporeal membrane oxygenation.
Brudno DS; Boedy RF; Kanto WP
Pediatr Pulmonol; 1990; 9(1):19-23. PubMed ID: 2388774
[TBL] [Abstract][Full Text] [Related]
26. A novel approach to ductal spasm during percutaneous device occlusion of patent ductus arteriosus.
De Decker R; Comitis G; Thomas J; van der Merwe E; Lawrenson J
Cardiol Young; 2016 Oct; 26(7):1352-8. PubMed ID: 26692358
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S; Hundalani SG; Kulkarni M; Fernandes CJ; Cabrera AG; Shivanna B; Pammi M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011417. PubMed ID: 29486048
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.
Buck ML
DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911
[TBL] [Abstract][Full Text] [Related]
29. Congenital heart disease with ductal-dependent systemic perfusion: Doppler ultrasonography flow velocities are altered by changes in the fraction of inspired oxygen.
Day RW; Tani LY; Minich LL; Shaddy RE; Orsmond GS; Hawkins JA; McGough EC
J Heart Lung Transplant; 1995; 14(4):718-25. PubMed ID: 7578181
[TBL] [Abstract][Full Text] [Related]
30. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
Park IS; Nihill MR; Titus JL
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
[No Abstract] [Full Text] [Related]
31. Successful use of oral prostaglandin E1 derivative for maintaining ductus-dependent systemic circulation in a neonate with trisomy 18.
Miyake A; Okada S; Ishikawa Y
Cardiol Young; 2019 Sep; 29(9):1222-1224. PubMed ID: 31434595
[TBL] [Abstract][Full Text] [Related]
32. Stenting the patent ductus arteriosus in duct-dependent pulmonary circulation: techniques, complications and follow-up issues.
Alwi M
Future Cardiol; 2012 Mar; 8(2):237-50. PubMed ID: 22413983
[TBL] [Abstract][Full Text] [Related]
33. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
[TBL] [Abstract][Full Text] [Related]
34. Accidental azygos vein extracorporeal membrane oxygenation cannulation in a neonate with premature closure of the ductus arteriosus.
Byrnes J; Prodhan P; Imamura M; Frazier E
ASAIO J; 2011; 57(4):344-5. PubMed ID: 21546823
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin Infusion in Neonate With Severe Coarctation of the Aorta With Closed Ductus Arteriosus-A Case Report and Review of the Literature.
Bansal N; Balakrishnan PL; Aggarwal S
World J Pediatr Congenit Heart Surg; 2020 Jul; 11(4):NP239-NP243. PubMed ID: 31010402
[TBL] [Abstract][Full Text] [Related]
36. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
[TBL] [Abstract][Full Text] [Related]
37. [Persistent pulmonary hypertension in a newborn infant treated with extracorporeal membrane oxygenation].
Hansen TW; Sponheim S; Pedersen T; Svennevig J
Tidsskr Nor Laegeforen; 1995 Feb; 115(5):591-4. PubMed ID: 7900111
[TBL] [Abstract][Full Text] [Related]
38. Supportive and emergency use of prostaglandin in the neonate with congenital heart disease.
Hussain A; al Khudhairi D
Middle East J Anaesthesiol; 1993 Feb; 12(1):73-81. PubMed ID: 8316154
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin-induced hyperostosis. A case report.
Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E1 overdose in a term neonate with congenital heart disease.
Gorodetsky RM; Toole BM; Schult RF; Wiegand TJ
Clin Toxicol (Phila); 2019 Jun; 57(6):420-421. PubMed ID: 30451018
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
